Skip to main content
. 2022 Jan 18;11:783335. doi: 10.3389/fonc.2021.783335

Table 3.

Univariate and multivariate analysis of risk factors of tumor recurrence in 122 patients.

Univariate Multivariate
HR (95%CI) P HR (95%CI) p
Age ≥55 0.88 (0.57–1.36) 0.576
male 0.57 (0.28–1.14) 0.111
Size ≥ 5cm 1.9 (1.12 –3.24) 0.018 2.13 (1.23–3.69) 0.007
Multiple tumors 1.44 (0.92–2.25) 0.114
Vascular invasion
Macro-VI 2.41 (1.52–3.84) <0.001 2.08 (1.29–3.37) 0.003
Micro-VI 1.5 (0.97–2.34) 0.071 1.61 (1.02–2.55) 0.042
Poor differentiation 1.15 (0.75–1.76) 0.516
Child B 1.1 (0.48–2.50) 0.823
AFP ≥200 1.61 (1.04–2.49) 0.032 1.42 (0.91–2.20) 0.122
PD-L1 ≥3.0 1.66 (1.07–2.57) 0.023 1.88 (1.18–2.99) 0.008
PD-1 >1.0 1.31 (0.81–2.14) 0.269
Liver cirrhosis 1.28 (0.82–2.00) 0.281

HRs, hazards ratios; CI, confidence intervals; AFP, alpha fetoprotein; PD-L1, programmed death-ligand 1; PD-1, programmed cell death protein 1.